SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-003817
Filing Date
2019-03-25
Accepted
2019-03-25 09:31:33
Documents
75
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1193082
2 ex23-1.htm EX-23.1 4402
3 ex31-1.htm EX-31.1 11475
4 ex31-2.htm EX-31.2 12070
5 ex32-1.htm EX-32.1 9181
  Complete submission text file 0001493152-19-003817.txt   4669588

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE eton-20181231.xml EX-101.INS 578711
7 XBRL SCHEMA FILE eton-20181231.xsd EX-101.SCH 54368
8 XBRL CALCULATION FILE eton-20181231_cal.xml EX-101.CAL 57635
9 XBRL DEFINITION FILE eton-20181231_def.xml EX-101.DEF 223918
10 XBRL LABEL FILE eton-20181231_lab.xml EX-101.LAB 399454
11 XBRL PRESENTATION FILE eton-20181231_pre.xml EX-101.PRE 335673
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38738 | Film No.: 19701487
SIC: 2834 Pharmaceutical Preparations